In this issue:
Genetic determinants of dabigatran concentrations
Characteristics of a dabigatran antidote
No-prophylaxis platelettransfusions for haematological cancers
CSF3R mutations in CNL and atypical CML
Indications, complications and management of IVC filters
Selective D-dimer testing for diagnosing a first DVT
Dexamethasone ± rituximab in newly diagnosed primary ITP
Anagrelide vs. hydroxyurea in WHO-classified ET
Factor VIII products and inhibitors in severe haemophilia A
Wells score and D-dimer for diagnosing isolated distal DVT
Please login below to download this issue (PDF)